Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets... Show more
LOVFF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where LOVFF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LOVFF's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on September 29, 2025. You may want to consider a long position or call options on LOVFF as a result. In of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LOVFF just turned positive on September 29, 2025. Looking at past instances where LOVFF's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LOVFF advanced for three days, in of 115 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
LOVFF moved below its 50-day moving average on September 05, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LOVFF crossed bearishly below the 50-day moving average on September 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LOVFF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LOVFF entered a downward trend on October 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LOVFF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.734) is normal, around the industry mean (17.817). P/E Ratio (10.600) is within average values for comparable stocks, (73.694). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.995). LOVFF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.623) is also within normal values, averaging (46.700).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry PharmaceuticalsGeneric
A.I.dvisor tells us that LOVFF and VPHIF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LOVFF and VPHIF's prices will move in lockstep.
Ticker / NAME | Correlation To LOVFF | 1D Price Change % | ||
---|---|---|---|---|
LOVFF | 100% | N/A | ||
VPHIF - LOVFF | 17% Poorly correlated | N/A | ||
KKPCF - LOVFF | 6% Poorly correlated | N/A | ||
VTRS - LOVFF | 3% Poorly correlated | -0.59% | ||
VEXTF - LOVFF | 1% Poorly correlated | +2.19% | ||
GEDSF - LOVFF | -0% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To LOVFF | 1D Price Change % |
---|---|---|
LOVFF | 100% | N/A |
Pharmaceuticals: Generic industry (222 stocks) | 16% Poorly correlated | +0.16% |
Pharmaceuticals industry (386 stocks) | 4% Poorly correlated | +0.20% |